This study was aimed at improving the RT-QuICbased system for the diagnosticsof neurodegenerative synucleinopathies and, in particular, at developing amethod for the production of highly purified recombinant monomeric wild-typeα-synuclein for its further use as a substrate in the RT-QuIC assay. Here, SNCA is linked to synucleinopathy.